JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹55 Cr | ₹35 Cr | ₹47 Cr | ₹6.91 Cr | ₹28 Cr |
What is the latest Cash Flow from Operating Activities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹35 Cr |
| Mar2023 | ₹47 Cr |
| Mar2022 | ₹6.91 Cr |
| Mar2021 | ₹28 Cr |
How is Cash Flow from Operating Activities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | 57.25 | |
| Mar2024 | ₹35 Cr | -24.63 | |
| Mar2023 | ₹47 Cr | 574.79 | |
| Mar2022 | ₹6.91 Cr | -75.50 | |
| Mar2021 | ₹28 Cr | - | |
Compare Cash Flow from Operating Activities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,521.6 Cr | 4% | 10.5% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | 4% |
10.5% |
3.9% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses